by North Woods | Mar 4, 2026 | Blog, Perspectives
By Paul Weiss, PhD, Partner at Clarevia In breast cancer, there was a moment when outcomes changed dramatically, but only for certain patients. Herceptin, an antibody therapy, was developed to target an overexpression of the HER2 protein. If a patient was...
by North Woods | Jan 20, 2026 | Blog, Portfolio Spotlights
For millions of people living with glaucoma, treatment often begins with a familiar daily routine: prescription eye drops lined up on the bathroom counter, reminders taped to mirrors, and the quiet worry that missing a dose could allow the disease to progress. As...
by North Woods | Dec 15, 2025 | Blog, Portfolio Spotlights
For many families, the journey to an autism diagnosis begins with a quiet worry—a toddler who isn’t talking yet, a pediatrician who shares their concern, and then a waitlist that stretches six, twelve, sometimes even twenty-four months. In that time, the most powerful...
by North Woods | Dec 2, 2025 | Blog, Portfolio Spotlights
The untold story behind HistoSonics and the collisions that drive true medical breakthroughs By Dr. Joe Amaral, Chief Medical and Scientific Officer at Clarevia Innovation rarely happens in a straight line. It’s a story of collisions—between people, ideas, timing, and...
by North Woods | Sep 23, 2025 | Blog, Firm News
Photo: Rivermark team members (from left to right)—Tristen Moors, Vice President Clinical Operations; Jaime Walkowiak, Executive Vice President of Operations; Greg Borecki, Vice President Market Development; Adam Kadlec, President & CEO; Andy Doraiswamy, Board...
